Mar 30

BioCopy Holding AG and Institute of Virology and Immunology (IVI) announce collaboration on African swine fever

Unlike classical swine fever, there is no vaccine against African swine fever. However, it has enormous economic potential. Just one infected wild boar can lead to a ban on pork exports to important third countries.

The aim of the cooperation is to develop a so-called marker vaccine. Positive effect: It serves not only for prevention, but also for diagnostics.

Read Press Release